Drugs : (Record no. 45034)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01222cam a2200337 a 4500 |
001 - CONTROL NUMBER | |
control field | 091239 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20210921174928.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 030923s2004 njua b 001 0 eng c |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 0471601500 (cloth) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780471601500: |
Terms of availability | £38.95 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | PUL |
Transcribing agency | PUL |
Modifying agency | NLM |
-- | TKN |
-- | OCL |
-- | BAKER |
-- | NLGGC |
042 ## - AUTHENTICATION CODE | |
Authentication code | pcc |
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.19 |
Item number | NG |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Ng, Rick. |
9 (RLIN) | 41189 |
245 10 - TITLE STATEMENT | |
Title | Drugs : |
Remainder of title | from discovery to approval / |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Place of publication, distribution, etc. | Hoboken, N.J. : |
Name of publisher, distributor, etc. | Wiley-Liss, |
Date of publication, distribution, etc. | 2004. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | xii, 355 p. : |
Other physical details | ill. ; |
Dimensions | 24 cm. |
336 ## - CONTENT TYPE | |
Content type term | text |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | unmediated |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | volume |
Source | rdacarrier |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc. note | Includes bibliographical references and index. |
520 8# - SUMMARY, ETC. | |
Summary, etc. | This volume offers a step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls and manufacturing of drugs. |
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pharmaceutics |
General subdivision | Research |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug development. |
9 (RLIN) | 32738 |
902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) | |
a | 170509 |
907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) | |
a | .b10477688 |
b | smmai |
c | - |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Suppress in OPAC | 0 |
948 ## - LOCAL PROCESSING INFORMATION (OCLC); SERIES PART DESIGNATOR (RLIN) | |
h (OCLC) | NO HOLDINGS IN LQI - 279 OTHER HOLDINGS |
998 ## - LOCAL CONTROL INFORMATION (RLIN) | |
Operator's initials, OID (RLIN) | 0 |
Cataloger's initials, CIN (RLIN) | 060726 |
First Date, FD (RLIN) | m |
Local | a |
-- | 0 |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Cost, normal purchase price | Total Checkouts | Total Renewals | Full call number | Barcode | Date last seen | Copy number | Cost, replacement price | Price effective from | Koha item type | Date last checked out | Checked out |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other/Generic Classification Scheme | ATU Sligo Yeats Library | ATU Sligo Yeats Library | Main Lending Collection | 26/07/2006 | 56.80 | 26 | 18 | 615.19 NG | 0052458 | 06/06/2017 | 1 | 56.80 | 06/06/2017 | Standard Loan | ||||||
Other/Generic Classification Scheme | ATU Sligo Yeats Library | ATU Sligo Yeats Library | Main Lending Collection | 06/09/2007 | 61.34 | 10 | 15 | 615.19 NG | 0066908 | 30/08/2022 | 2 | 61.34 | 06/06/2017 | Standard Loan | 31/01/2022 | |||||
Lost | Other/Generic Classification Scheme | ATU Sligo Yeats Library | ATU Sligo Yeats Library | Main Lending Collection | 20/09/2007 | 58.80 | 14 | 19 | 615.19 NG | 0057943 | 06/06/2017 | 3 | 58.80 | 06/06/2017 | Standard Loan | 12/10/2016 | 24/04/2017 |